Systemic trichosporonosis mimicking disseminated varicella zoster viral infection during blinatumomab therapy
Sign Up to like & getrecommendations! Published in 2017 at "Annals of Hematology"
DOI: 10.1007/s00277-017-3153-0
Abstract: Dear Editor, Blinatumomab is a T cell engager antibody with bi-specificity for CD3 and CD19. By binding to both antigens, blinatumomab directs CD3+ cytotoxic T cells to destroy CD19-expressing neoplastic B cells. The spectrum of… read more here.
Keywords: blinatumomab therapy; infection; therapy; varicella zoster ... See more keywords
Bone Marrow Necrosis in a Patient Following Blinatumomab Therapy.
Sign Up to like & getrecommendations! Published in 2019 at "Journal of Pediatric Hematology/Oncology"
DOI: 10.1097/mph.0000000000001532
Abstract: Bone marrow necrosis (BMN) is an extremely rare condition characterized by necrosis of the myeloid tissue and medullary stroma leaving an amorphous eosinophilic background and ill-defined necrotic cells in the hematopoietic bone marrow. Several conditions… read more here.
Keywords: blinatumomab therapy; following blinatumomab; marrow necrosis; bone marrow ... See more keywords